Table 3.

Multivariate analysis of risk factors for tigecycline-associated hypofibrinogenaemia

Variable	OR	95% CI	p
Maintenance dose	1.998	1.037–3.849	0.039
Treatment course	1.152	1.053–1.260	0.002
Fibrinogen level when staring to use tigecycline	0.558	0.414–0.752	< 0.001
Intra-abdominal infection	11.420	2.069–63.050	0.005

OR odds ratio, CI confidence interval